GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt flag Egypt · Delayed Price · Currency is EGP
68.18
+11.36 (19.99%)
At close: Sep 7, 2025

GlaxoSmithKline S.A.E Market Cap

GlaxoSmithKline S.A.E has a market cap or net worth of 5.71 billion as of September 8, 2025. Its market cap has increased by 143.94% in one year.

Market Cap
5.71B
Enterprise Value
5.48B
Revenue
3.52B
Ranking
n/a
PE Ratio
39.00
Stock Price
68.18

Market Cap Chart

Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 5.71B, an increase of 903.13%. That is a compound annual growth rate of 12.18%.

History

DateMarket Cap% Change
Sep 7, 20255.69B89.39%
Dec 31, 20243.01B1.27%
Dec 31, 20232.97B-6.84%
Dec 29, 20223.19B23.58%
Dec 30, 20212.58B82.08%
Dec 31, 20201.42B-14.17%
Dec 31, 2019 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition